Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2016Thrombosis and Haemostasis

Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJohnny MahlanguNational Health Laboratory ServiceMRMargaret V. RagniUniversity of PittsburghNGNaresh GuptaMaulana Azad Medical College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mahlangu et al. (2016) studied this question.

synapsesocial.com/papers/6a9720248a4936f1ceb317eahttps://doi.org/10.1160/th15-10-0780
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy of a sucrose‐formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A2000 · 29 citations
  2. 2Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEG ylated recombinant factor VIII ( BAY 94‐9027) for haemophilia A2014 · 70 citations
  3. 3Aspects of current management: orthopaedic surgery in haemophilia2011 · 111 citations
  4. 4Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A2013 · 453 citations